Цетилпиридиния хлорид

What it is

Cetylpyridinium chloride (CPC) is a quaternary ammonium compound first synthesised in the 1930s. It is now one of the most studied antiseptics in over-the-counter oral care — included in the FDA monograph for oral antiseptics and found in rinses across every market segment, from drugstore basics to premium lines.

The molecule has two structural features that define everything it does: a long 16-carbon hydrophobic alkyl tail and a positively charged pyridinium ring. That combination makes it an effective membrane-disrupting agent.

How it works

Bacterial cell membranes carry a net negative surface charge. The cationic CPC molecule is attracted to them electrostatically — it binds to the surface without needing any activation.

Then the hydrophobic tail inserts into the lipid bilayer. The membrane loses its structural integrity. Permeability increases sharply: potassium ions, proteins, and enzymes leak out of the cell. Metabolism collapses. The bacterium dies.

Cetylpyridinium chloride disrupts the integrity of bacterial cell membranes through electrostatic attraction followed by hydrophobic insertion, resulting in leakage of intracellular contents and cell death. — Souza JGS et al., 2020, PMC7526810

CPC is active against a broad spectrum of gram-positive and gram-negative bacteria, lipid-enveloped viruses, and certain fungi. Some gram-negative species are less susceptible due to their outer membrane architecture — but the organisms most responsible for plaque, gingivitis, and halitosis are well within range.

Unlike chlorhexidine, CPC does not exhibit significant substantivity. It does not bind to oral tissues and release gradually over 8–12 hours. That means shorter-acting protection — and meaningfully less disruption to the stable oral microbiome.

CPC versus chlorhexidine

Both are cationic surfactants. Both disrupt bacterial membranes. But they occupy different clinical roles.

| Parameter | CPC 0.05–0.07% | Chlorhexidine 0.12–0.2% | |---|---|---| | Plaque reduction | moderate | high | | Gingivitis reduction | comparable | high | | Halitosis reduction | comparable | comparable | | Tooth staining | minimal | significant | | Microbiome impact | mild | substantial | | Appropriate use | daily maintenance | short courses, by prescription | | Taste disturbance | rare | common |

A 2025 meta-analysis by Windhorst et al. (PMC12516004) reviewed 18 direct comparisons of CPC and chlorhexidine across clinical trials. Chlorhexidine showed a marginal advantage in plaque index scores. On halitosis, both agents performed equally. On the combined benefit-risk profile for daily use, CPC is the better choice.

Both agents showed comparable efficacy in reducing halitosis scores. For daily maintenance use, CPC presents a more favourable benefit-risk profile than chlorhexidine. — Windhorst K et al., Int J Dent Hyg, 2025, PMC12516004

Clinical evidence

A six-month randomised controlled trial by Haps et al. (2008, PubMed 24024983) tested 0.07% CPC rinse under real-world daily conditions. At the six-month mark, the CPC group showed statistically significant plaque reductions. The placebo group showed none.

Quirynen et al. (2016, PMC5113089) studied CPC in an experimental gingivitis model: 91 participants suspended all mechanical tooth cleaning for 21 days, using only a CPC rinse or water. Gingival inflammation progressed significantly more slowly in the CPC group. Importantly, CPC slowed the maturation of the biofilm itself — disrupting the transition from early, benign colonisers to a more pathogenic community.

Concentrations

The effective range is 0.05–0.1%.

Most mouthwashes use 0.05–0.07%. At these concentrations, CPC delivers antibacterial and anti-plaque effects adequate for daily maintenance without meaningfully increasing the risk of mucosal irritation. Concentrations above 0.1% do not produce proportional gains in efficacy.

The FDA recognises 0.025–0.1% CPC as safe for OTC use as an oral antiseptic.

Safety for daily use

The most important question for a daily-use antiseptic is not whether it kills bacteria. It is what it does to the rest of the oral ecosystem.

Shinada et al. (1997, PMID 9080738) followed participants using 0.05% CPC for six weeks and found no significant changes in colony-forming unit counts across key microbial taxa. The systematic review by Amaral et al. (2023) confirms this pattern: CPC selectively reduces pathogen-associated bacteria without broadly suppressing microbial diversity — in contrast to chlorhexidine, which causes more sweeping compositional shifts.

Tooth staining with CPC at standard concentrations is rare and mild. The mechanism differs from chlorhexidine: CPC does not bind as persistently to enamel, and the pigment-fixation reaction that produces chlorhexidine's characteristic brown staining does not occur with CPC.

Mucosal irritation at 0.05–0.07% is minimal. Systemic absorption during rinsing is negligible.

QDRO position

There are antiseptics you prescribe for problems. And there are antiseptics you build into a daily routine.

CPC belongs to the second category. In v.daily rinses, it suppresses the growth of pathogenic bacteria, slows biofilm formation, and reduces the volatile sulphur compounds behind bad breath. Without staining. Without disrupting taste. Without knocking out the healthy bacteria that protect the oral mucosa.

That is not a trade-off. That is the point of choosing the right tool for the job.